Arthritis & Rheumetology Clinic is categorized under Health Services in Chandler, AZ and active since 2010.
Arthritis & Rheumetology Clinic was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Mohammad Shakir at the company’s single location by writing to 1100 South Dobson Road # 102, Chandler, Arizona AZ 85286 or by phoning (480) 855-4078. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Arthritis & Rheumetology Clinic |
| Contact Person: | Mohammad Shakir |
| Address: | 1100 South Dobson Road # 102, Chandler, Arizona 85286 |
| Phone Number: | (480) 855-4078 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6211110 |
| Share This Business: |
Arthritis & Rheumetology Clinic was started in 2010 to provide professional Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mohammad Shakir for inquiries that concern Arthritis & Rheumetology Clinic by calling the company number (480) 855-4078, as your correspondence is most welcome. Additionally, the physical location of the single location of Arthritis & Rheumetology Clinic can be found at the coordinates 33.29109,-111.87637 as well as the street address 1100 South Dobson Road # 102 in Chandler, Arizona 85286.
For its online presence, you may visit Arthritis & Rheumetology Clinic’s website at and engage with its social media outlets through on Twitter and on Facebook.